Cibc World Market Inc. Sells 8,772 Shares of Intuitive Surgical, Inc. $ISRG

Cibc World Market Inc. decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 60,120 shares of the medical equipment provider’s stock after selling 8,772 shares during the quarter. Cibc World Market Inc.’s holdings in Intuitive Surgical were worth $26,887,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also added to or reduced their stakes in the company. Tobam grew its stake in shares of Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares during the last quarter. Kilter Group LLC purchased a new position in shares of Intuitive Surgical during the second quarter valued at about $27,000. Greykasell Wealth Strategies Inc. bought a new position in Intuitive Surgical in the third quarter worth about $27,000. Princeton Global Asset Management LLC purchased a new stake in Intuitive Surgical in the second quarter worth about $30,000. Finally, Guerra Advisors Inc purchased a new stake in Intuitive Surgical in the third quarter worth about $37,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Quarterly results and procedure growth support fundamentals. Intuitive reported a recent quarter that beat EPS and revenue estimates and showed high year‑over‑year revenue growth, and analysts continue to point to strong procedure trends and da Vinci 5 adoption — a fundamental driver that can support longer‑term revenue and system placements.
• Positive Sentiment: Industry commentary / analyst insights that highlight execution. Recent analyst notes (roundups) have discussed Intuitive alongside other healthcare names, keeping attention on the company’s execution and product cycle. Article Title
• Neutral Sentiment: Market data and charting reference. Interactive charting and market pages are being used by traders to monitor the pullback and technical levels (50‑day and 200‑day moving averages are near each other), supporting short‑term trading interest. Article Title
• Negative Sentiment: Executive insider selling disclosed this week. Multiple filings show senior executives (EVP Myriam Curet and VP Fredrik Widman) sold shares in early February, with some sales materially reducing their individual holdings — a near‑term negative signal for market sentiment. Filings: Myriam Curet SEC filing and Fredrik Widman SEC filing
• Negative Sentiment: Valuation debate / “priced for perfection” narrative. Commentary in the financial press is questioning whether ISRG’s valuation still assumes flawless execution after a recent pullback, raising investor caution around the stock’s premium multiple. Article Title
• Negative Sentiment: Recent share underperformance highlighted by analysts. Coverage notes that ISRG has fallen roughly mid‑double digits over the last three months despite ongoing procedure growth, which may have prompted short‑term selling pressure and re‑rating risk. Article Title
• Neutral Sentiment: Short interest data appears anomalous / not a clear driver. Recent short‑interest reports in the feed show zeros or NaN values and an effectively 0 days‑to‑cover figure — this looks like a data anomaly rather than confirmed heavy shorting, so it’s unlikely to be a meaningful market driver today.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $496.12 on Thursday. The company’s 50-day simple moving average is $545.21 and its 200-day simple moving average is $510.52. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $609.08. The stock has a market capitalization of $176.19 billion, a P/E ratio of 62.88, a P/E/G ratio of 3.84 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. During the same period last year, the business posted $2.21 earnings per share. The firm’s revenue was up 18.8% compared to the same quarter last year. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Ratings Changes

ISRG has been the subject of several analyst reports. Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 29th. Leerink Partners upped their price target on Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. Mizuho set a $575.00 target price on shares of Intuitive Surgical in a report on Wednesday, October 22nd. The Goldman Sachs Group reaffirmed a “buy” rating and set a $714.00 price objective on shares of Intuitive Surgical in a report on Friday, January 9th. Finally, Wall Street Zen cut Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $617.23.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 4,500 shares of the business’s stock in a transaction that occurred on Friday, December 12th. The shares were sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the sale, the senior vice president owned 907 shares of the company’s stock, valued at approximately $496,455.52. The trade was a 83.23% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Fredrik Widman sold 133 shares of the company’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the completion of the transaction, the vice president directly owned 660 shares in the company, valued at approximately $326,673.60. The trade was a 16.77% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 56,189 shares of company stock valued at $30,785,441. Company insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.